IVVvsPBE
iShares Core S&P 500 ETF against Invesco Dynamic Biotechnology & Genome ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IVV | PBE | |
|---|---|---|
| Expense ratio | 0.030% | 0.58% |
| Assets | $889.4B | $398M |
| Net flow, 1 month | −$6.7B | +$90M |
| Net flow, 1 year | +$97.3B | +$88M |
| Return, YTD | +12.1% | +18.5% |
| Return, 1 year | +18.6% | +41.8% |
| Avg daily volume | 4.5M | 52K |
| Holdings | 507 | 31 |
| Listed | May 14, 2000 | Jun 22, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS